Clinical Oncology
Volume 22, Issue 2 , Pages 140-146 , March 2010

Is There a Role for Adjuvant Hysterectomy after Suboptimal Concurrent Chemoradiation in Cervical Carcinoma?

  • N. Walji

      Affiliations

    • The Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • Corresponding Author InformationAuthor for correspondence: N. Walji, The Cancer Centre, Queen Elizabeth Hospital, Vincent Drive, Birmingham B15 2TH, UK. Tel: +44-121-697-8319; Fax: +44-121-627-2443.
    • ,
  • A.L. Chue

      Affiliations

    • The Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • ,
  • C. Yap

      Affiliations

    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham, UK
    • ,
  • L.J. Rogers

      Affiliations

    • Pan-Birmingham Gynaecology Cancer Centre, City Hospital, Birmingham, UK
    • ,
  • A. El-Modir

      Affiliations

    • The Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • ,
  • K.K. Chan

      Affiliations

    • Birmingham Women's Hospital, Birmingham, UK
    • ,
  • K. Singh

      Affiliations

    • Pan-Birmingham Gynaecology Cancer Centre, City Hospital, Birmingham, UK
    • ,
  • I.N. Fernando

      Affiliations

    • The Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK

Received 26 June 2009 ,Revised 9 October 2009 ,Accepted 10 November 2009.

References 

  1. Nag S, Chao C, Erickson B, et al., for the American Brachytherapy Society  The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;52:33–48
  2. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–211
  3. King M, McConkey C, Latief TN, Hartley A, Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol). 2006;18:38–45
  4. Spensley S, Hunter RD, Livsey JE, Swindell R, Davidson SE. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol (R Coll Radiol). 2009;21:49–55
  5. Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer – the Addenbrooke's experience. Clin Oncol (R Coll Radiol). 2008;20:358–364
  6. Lodgson MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–775
  7. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys. 1991;20:667–676
  8. Lanciano RM, Martz K, Coia LR, Hanks GE. Tumours and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 1991;20:95–100
  9. Perez CA, Breaux S, Madoc-Jones H, et al. Radiation therapy alone in carcinoma of the uterine cervix. I. Analysis of tumour recurrence. Cancer. 1983;51:1393–1402
  10. Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The patterns of care outcome study for cancers of the uterine cervix. Results of the second National practice survey. Cancer. 1990;66:2451–2456
  11. Yalman D, Aras AB, Ozkok S, et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol. 2003;24:309–314
  12. Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with or without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003;89:343–353
  13. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WS, Million RR. Stage IB or IIA-IIB carcinoma of the intact uterine cervix greater than or equal to 6cm in diameter: is adjuvant extrafascial hysterectomy beneficial?. Int J Radiat Oncol Biol Phys. 1991;21:899–904
  14. Rotman M, John MJ, Moon SH, et al. Limitations of adjunctive surgery in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1979;5:327–332
  15. Classe JM, Rauch P, Rodier JF, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Lutte Contre le Cancer). Gynecol Oncol. 2006;102:523–529
  16. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Eng J Med. 1999;340:1154–1161
  17. Christianson MS, Barker MA, Lindheim SR. Overcoming the challenging cervix: techniques to access the uterine cavity. J Low Genit Tract Dis. 2008;12:24–31
  18. Corn BW, Shaktman BD, Lanciano RM, et al. Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer. Gynecol Oncol. 1997;64:224–229
  19. Morice P, Uzan C, Zafrani Y, Delpech Y, Guoy S, Haie-Meder C. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer. Gynecol Oncol. 2007;107:S122–S124
  20. Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K. Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy. Br J Cancer. 2008;99:1216–1220
  21. Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of post-therapy positron emission tomography with tumour response and survival in cervical carcinoma. J Am Med Assoc. 2007;298:2289–2295
  22. Rutledge S, Carey MS, Prichard H, Allen HH, Kocha W, Kirk ME. Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary?. Gynecol Oncol. 1994;52:353–359
  23. Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994;55:29–35
  24. Tan LT, Coles CE, Hart C, Tait E. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator – the Addenbrooke's experience. Clin Oncol (R Coll Radiol). 2009;21:175–182

PII: S0936-6555(09)00376-8

doi: 10.1016/j.clon.2009.11.006

Clinical Oncology
Volume 22, Issue 2 , Pages 140-146 , March 2010

Article Tools

* Image Usage & Resolution